Screener
Dianthus Therapeutics DNTH Operating Lease Liabilities
Operating Lease Liabilities at other companies
Other financials
Where this comes from
Reported directly by Dianthus Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:OperatingLeaseLiabilityNoncurrent.
The source filing: Dianthus Therapeutics’s 10-Q, filed May 5, 2026.
- Filed
- May 5, 2026, 4:06 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001690585-26-000022
| Line item | March 31,2026 | December 31,2025 |
|---|---|---|
| Current portion of operating lease liabilities | 399 | 367 |
| Total current liabilities | 38,283 | 30,732 |
| Deferred revenue | 6,322 | 5,770 |
| Long-term operating lease liabilities | 965 | 1,019 |
| Total liabilities | 45,570 | 37,521 |
| Commitments and contingencies (Note 14) | ||
| Stockholders’ equity: | ||
| Preferred stock; $0.001 par value per share; authorized shares – 10,000,000 at March 31, 2026 and December 31, 2025; issued and outstanding – none at March 31, 2026 and December 31, 2025 | — | — |
Item 1. Condensed Consolidated Financial Statements (Unaudited)
FAQ
- What is Dianthus Therapeutics's operating lease liabilities?
- Dianthus Therapeutics (DNTH) reported operating lease liabilities of $965K in Q1 2026.
- How has Dianthus Therapeutics's operating lease liabilities changed year-over-year?
- Dianthus Therapeutics's operating lease liabilities decreased by 17.5% year-over-year, from $1.17M to $965K.
- What does operating lease liabilities mean?
- Long-term portion of operating lease obligations extending beyond one year, representing committed future rent payments.
Ask your AI about Dianthus Therapeutics's operating lease liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude